Table 2.
CD4+ and CD8+ T-cell differentiation status in lymph node with regard to the development of rejection.
| n | No rejection | n | Rejection | p | |
|---|---|---|---|---|---|
| CD4+ | |||||
| CD4+CD28+CD27+ (%) | 25 | 93.8 (91.6–96.6) | 8 | 93.8 (81.1–94.7) | 0.578 |
| CD4+CD28nullCD27− (%) | 25 | 0.3 (0.1–0.6) | 8 | 0.2 (0.1–0.8) | 0.951 |
| CD4+CD28+PD-1− (%) | 25 | 73.5 (64.0–82.0) | 8 | 76.3 (72.0–80.4) | 0.665 |
| CD4+CD28nullPD-1+ (%) | 25 | 0.4 (0.2–0.9) | 8 | 0.5 (0.3–1.2) | 0.578 |
| CD4+CD28+CD57− (%) | 25 | 97.6 (95.3–98.6) | 8 | 97.0 (96.5–97.7) | 0.272 |
| CD4+CD28nullCD57+ (%) | 25 | 0.1 (0.0–0.2) | 8 | 0.1 (0.0–0.2) | 0.885 |
| CD8+ | |||||
| CD8+CD28+CD27+ (%) | 25 | 89.6 (84.1–93.3) | 8 | 90.4 (78.8–92.2) | 0.789 |
| CD8+CD28nullCD27− (%) | 25 | 1.9 (1.0–2.6) | 8 | 1.7 (1.0–6.5) | 0.789 |
| CD8+CD28+PD-1− (%) | 25 | 62.2 (49.5–75.1) | 8 | 66.9 (45.8–75.1) | 0.853 |
| CD8+CD28nullPD-1+ (%) | 25 | 2.4 (1.6–5.2) | 8 | 2.6 (1.6–4.8) | 0.951 |
| CD8+CD28+CD57− (%) | 25 | 87.4 (80.2–91.0) | 8 | 86.3 (75.5–88.8) | 0.374 |
| CD8+CD28nullCD57+ (%) | 25 | 1.5 (1.0–2.3) | 8 | 1.5 (0.9–4.3) | 0.757 |
Data are presented as medians (interquartile range).